Related Experiment Video
Updated: Jul 5, 2026

Treatment of Ejaculatory Duct Obstruction by Seminal Vesiculoscopy Assisted Flow Modification
Published on: December 8, 2023
[The treatment of vesicoureteral reflux]
Ribeiro de Castro1, Pedro Massó, Armando Reis
1Servicio de Urología, Hospital María Pia, Porto, Portugal. luis.joao.castro@gmail.com
Insights
Subureteral injection of dextranomer and hyaluronic acid copolymer effectively treats pediatric vesicoureteral reflux (VUR). This minimally invasive endoscopic procedure offers a safe and well-tolerated surgical option with a high success rate, becoming a preferred treatment for VUR.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
- Urologic Pathology
Background:
- Vesicoureteral reflux (VUR) is a common condition in children, often diagnosed during urinary tract infection (UTI) investigations or prenatal hydronephrosis screening.
- The management of VUR has evolved, with minimally invasive endoscopic techniques gaining prominence.
- Subureteral injection of bulking agents represents a significant advancement in VUR treatment options.
Purpose of the Study:
- To evaluate the efficacy and outcomes of endoscopic treatment for VUR using subureteral injection of dextranomer and hyaluronic acid copolymer.
- To present surgical treatment results for VUR in children between 2001 and 2006.
Main Methods:
- Retrospective study of endoscopic VUR treatment with dextranomer and hyaluronic acid copolymer (Copol-Dx/AH) from July 2001 to December 2006.
- Inclusion criteria: children with VUR grade II or greater undergoing treatment.
- Cure defined as no reflux or grade I VUR on control voiding cystourethrography (VCUG), with subsequent discontinuation of antibiotic prophylaxis.
Main Results:
- A total of 661 children were treated; 607 endoscopically and 54 with the Cohen technique.
- Endoscopic treatment involved 437 females and 170 males, with bilateral VUR in 37.7% of cases.
- Success rates were 70% after the first treatment, 75% after the second, and 78% after the third.
Conclusions:
- Subureteral injection of dextranomer and hyaluronic acid copolymer is an effective treatment for pediatric VUR, regardless of reflux grade.
- The procedure is simple, safe, well-tolerated, and associated with low morbidity.
- Endoscopic treatment is currently the preferred surgical option for most children with VUR.
Objectives:
Vesicoureteral reflux (VUR) is a frequent pathology, with an incidence of 29/50% in children studied for urinary tract infection (UTI) and 20% of newborns with the diagnosis of prenatal hydronephrosis. Over the years, the treatment has been the subject of many meetings, many research studies, and continues being a topic under discussion. The number of candidates for surgical treatment increased with the development of minimally invasive endoscopic techniques by subureteral injection of bulking agents. We present the results of the surgical treatment of VUR between 2001 and 2006.
Methods:
We performed a retrospective study of the endoscopic treatment of VUR by subureteral injection of Dextranomer and hyaluronic acid copolymer (Copol-Dx/AH). All children undergoing treatment between July 1st 2001 and December 30th 2006 were included in this study. Treatment was performed in children with VUR grade II or greater. All patients presenting no reflux or grade I VUR on control VCUG were considered cured; stopping antibiotic prophylaxis was proposed in these cases.
Results:
661 children underwent treatment, 607 endoscopic and 54 with the Cohen technique. Among children treated endoscopically, 437 where females and 170 males. VUR was bilateral in 37.7% of the cases, with grade II being the most frequent (40% in males and 57% in females). Overall success rate was 70% after first treatment, 75% after second treatment and increased to 78% after the third.
Conclusions:
Subureteral injection of dextranomer and hyaluronic acid copolymer is on effective treatment in children with VUR, independently of the grade. It is a simple, safe, well tolerated procedure with low associated morbidity. Currently, it is the surgical treatment of choice in most patients with VUR.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi VI: Surgical Management
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urinary Tract Infection IV: Nursing Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urinary Tract Calculi V: Nursing Management